Amid Nasdaq’s Worst Week in a Year, Three New Listings Stand Out
Two biotech IPOs and an AI infrastructure stock rose sharply on their early trading days even as the Nasdaq tumbled on broader tech weakness.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Two biotech IPOs and an AI infrastructure stock rose sharply on their early trading days even as the Nasdaq tumbled on broader tech weakness.
Kalshi traders now price in a greater-than-even chance of a Tesla–SpaceX merger by spring 2027 following the Roadster debut.
Microsoft will fund new generation, raising projected NIPSCO customer savings to $1.75 billion.
Delivery now delayed to December or later.
Travelers delivered a strong third-quarter profit and beat consensus, but higher storm losses and flat premium growth weighed on the stock.
BMO lifts Semtech target to $230 as the company raises Q3 guidance and unveils a $3.2B FY2030 framework with strong data center growth and margins.